Thromboprophylaxis post vaginal delivery: are we forgetting it? Audit on thromboprophylaxis prescription post vaginal births.
Pulmonary thromboembolism is the leading direct cause of maternal deaths in the UK. The majority of deaths occur in the puerperium. Caesarean section has been recognised as a risk factor but there is concern that more attention to thromboprophylaxis after vaginal births is needed. The hospital maternity unit in Dumfries has written guidelines on thromboprophylaxis after vaginal births. This audit assessed the compliance with these guidelines within this maternity unit. The case notes relating to spontaneous vaginal births over a 2-month period (n=148) and instrumental vaginal births over a 7-month period (n=29) were reviewed. Information concerning venous thromboembolism risk and any thromboprophylaxis given was extracted. The audit showed that 9% of spontaneous vaginal births and 62% of instrumental vaginal births required specific thromboprophylaxis. However, only 31% of the spontaneous vaginal births and 22% of the instrumental vaginal births in which thromboprophylaxis was indicated did indeed receive the required treatment. Failure to respond to venous thromboembolism risk factors was common. Measures to increase the awareness of maternity staff to these factors are suggested.
Tan
E K
EK
Department of Obstetrics & Gynaecology, Dumfries and Galloway Royal Infirmary, Dumfries, UK. e_k_tan@yahoo.co.uk
Wisdom
S J
SJ
D000925:Anticoagulants / Q000627:therapeutic use; D001458:Bandages; D003681:Dehydration / Q000517:prevention & control; D036861:Delivery, Obstetric; D004434:Early Ambulation; D017984:Enoxaparin / Q000627:therapeutic use; D005260:Female; D019983:Guideline Adherence; D006801:Humans; D008485:Medical Audit; D011181:Postnatal Care / Q000379:methods*; D010818:Practice Patterns, Physicians'; D011655:Pulmonary Embolism / Q000517:prevention & control; D012189:Retrospective Studies; D012606:Scotland; D020246:Venous Thrombosis / Q000517:prevention & control*
D000925:Anticoagulants; D017984:Enoxaparin